<ul>
<li>ALHC 股票飙升 400%——以下是牛市未结束的原因</li>
</ul>
<p>Alignment Healthcare NASDAQ: ALHC 的高管表示，公司对第二季度的前景保持信心，指出医疗成本趋势稳定，利用率持续可见，并有机会在加州以外扩大利润空间。</p>
<p>获取 <strong>Alignment Healthcare</strong> 的提醒：</p>
<p>在一次由分析师主导的问答环节中，董事长兼首席执行官 John Kao 和首席财务官 Jim Head 讨论了医疗保险优势公司的指导方针、增长战略、提供者关系、风险调整环境和技术投资。</p>
<h2>高管表示医疗成本趋势保持稳定</h2>
<p>Head 表示，Alignment 的第二季度指导反映了上半年 “相当强劲的改善”，包括医疗福利比率改善 60 个基点，销售、一般和行政费用改善 40 个基点，以及调整后 EBITDA 改善近 100 个基点。他还指出，年同比增长达 80%。</p>
<p>当被问及第一季度到第二季度的医疗福利比率预期下降时，Head 表示这种模式是典型的，由两个因素驱动：第二季度与第一季度的不同利用季节性以及医疗保险 D 部分的影响。他表示，今年的下降幅度大于以往，约为 140 个基点，但补充说，考虑到一月的利用管理逆风、D 部分的影响以及去年第二季度的医疗成本较高，这一模式似乎是一致的。</p>
<p>“我们对第二季度的指导及其表现感到相当满意，” Head 说。</p>
<p>在医疗趋势方面，Head 描述情况为 “稳定”。他说，住院入院、急性和非急性住院成本、补充福利和 D 部分的表现均符合预期。尽管公司今年的会员组成有所不同，包括更多可能更急需的新增会员，但 Head 表示趋势与公司的预测保持一致。</p>
<h2>数据可见性仍然是 Alignment 模型的核心</h2>
<p>Kao 表示，Alignment 对医疗趋势的可见性源于一种 “自下而上构建” 的方式，从会员层面开始，汇总到团体和市场。他表示，公司跟踪的指标包括会员满意度、每千人入院率、再入院率、急诊室率、预防相关指标和质量。</p>
<p>“高质量、低成本” 是公司早期的指导原则，Kao 说。他补充说，Alignment 的系统使管理层能够每天审查数据，并识别每位会员每月的负面差异。</p>
<p>“这种透明度、可见性和控制力的概念导致了持久性，” Kao 说。他将 Alignment 的数据能力与竞争对手的后端系统进行了对比，后者可能需要 30 到 45 天的对账时间。</p>
<h2>Kao 认为风险调整变化不确定</h2>
<p>Kao 表示，2027 年最终费率通知比初步版本更好，部分原因是风险调整数据重新校准的延迟。他表示，Alignment 相信它可以在进入新的一年时做得比 2.48% 的整体费率增长更好，引用了公司的以护理为中心的模型。</p>
<p>尽管如此，Kao 表示，费率增长仍低于整体趋势，可能继续对竞争对手施加压力。他认为，Alignment 的低成本模型在费率持平或下降时给予了其优势。</p>
<p>在最近与华盛顿特区的讨论后，Kao 表示，目前尚不清楚医疗保险优势风险模型是否会在短期内发生重大变化。他表示，官员们似乎对是否有足够的时间实施更大变化持谨慎态度，包括与推断诊断相关的方法。</p>
<p>Kao 还表示，未来的关注可能会从健康计划转向更广泛的 “项目完整性”，涵盖整个医疗供应链，包括药房、欺诈、浪费和滥用，以及健康系统和综合交付网络的账单准确性。</p>
<h2>加州以外的扩张提供了利润机会</h2>
<p>Kao 表示，Alignment 对其在加州以外的增长感到满意，目前约 20% 的会员位于该地区。他表示，公司在今年有意捕捉 C-SNP 和 D-SNP 会员，他将其描述为最有利可图的人群，因为 Alignment 的护理模型。</p>
<p>他承认，加州以外的医疗损失比率自然较高，考虑到新增长的数量，但表示公司预计群体成熟和嵌入收益将有利于未来几年。</p>
<p>Kao 表示，扩张将继续通过过滤器进行评估，例如公司是否能够找到理解并支持 Alignment 模型的志同道合的提供者。他表示，公司计划在 2027 年进入已识别这些提供者的市场，包括对 Alignment 方法感兴趣的健康系统和潜在市场份额的增长。</p>
<p>在加州以外，Kao 表示，Alignment 通常作为 IPA 本身运作，直接与医生实践合作，解决星级评分差距、风险调整和整合其 Care Anywhere 临床模型。这与加州的部分地区不同，独立医生协会可能在公司与提供者之间。</p>
<p>“因为我们是 IPA，所以在加州以外的市场中我们有更多的利润机会，” Kao 说。</p>
<h2>技术、人工智能和利润目标</h2>
<p>Kao 表示，Alignment 在最近几个季度对其 AVA 技术平台 “故意保持低调”，因为它正在重建和增强技术架构。他表示，新的大型语言模型可以通过提供更快、更准确和及时的数据来改善工作流程，对医疗损失比率和一般及行政费用都有潜在好处。</p>
<p>“你们很快就会开始听到我们首先使用人工智能这个词，” Kao 说，并补充说，公司预计将在业务中部署人工智能用例。</p>
<p>高奥还讨论了最近的招聘情况，包括将专注于 AVA Health Partners 的马克·肯特，以及将作为首席运营官加入的香农·霍赫拉德尔，他在 Elevance Health 拥有索赔系统、提供者数据和提供者参与方面的经验。高奥还表示，现任董事会主席约瑟夫·科诺维基将承担更积极的战略角色，而高奥同意担任主席以维护治理结构。</p>
<p>关于长期盈利能力，高奥重申了 5% 到 6% 的利润空间机会，同时指出医疗保险优势计划 85% 的医疗损失率要求。他表示，Alignment 可以通过更丰富的补充福利、更强的提供者合作关系或其他支持可持续性的投资来满足该要求。</p>
<p>高奥表示，公司将继续在每个市场追求平衡增长和利润扩张，依靠技术和规模导向的领导力支持。他还重申了 Alignment 希望至少达到 100 万会员的雄心，尽管他拒绝提供时间表。</p>
<h2>关于 Alignment Healthcare NASDAQ: ALHC</h2>
<p>Alignment Healthcare, Inc NASDAQ: ALHC 是一家专注于为医疗保险优势受益人提供基于价值的医疗服务的公司。该公司利用一种综合护理模式，结合居家临床服务、远程医疗能力和数字健康工具，以管理慢性病、改善结果和提升患者体验。</p>
<p>Alignment Healthcare 方法的核心是一种专有技术平台，该平台聚合实时临床和索赔数据，以支持预防护理、风险分层和个性化护理计划。</p>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。如对本故事有任何问题或意见，请发送邮件至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资$1,000 在 Alignment Healthcare 吗？</h2>
<p>在考虑 Alignment Healthcare 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而 Alignment Healthcare 并不在名单上。</p>
<p>虽然 Alignment Healthcare 目前在分析师中获得了适度买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>查看这五只股票</p>

ALHC

美国医疗保健供应商 ETF - iShares

<p>Alignment Healthcare (NASDAQ:ALHC) 对其第二季度前景持乐观态度，指出医疗成本稳定以及加州以外的增长机会。高管们报告了医疗福利比率和调整后 EBITDA 的改善，年增长率达到 80%。他们强调了强大的数据可见性和以护理为中心的模式，这使他们在竞争中处于有利地位。预计扩展到新市场将提升利润率，尽管最初医疗损失比率较高。公司还在监测医疗保险优势风险模型的潜在变化及其对未来增长的影响</p>

<ul>
<li>ALHC Stock Surges 400%—Here’s Why the Bulls Aren’t Done</li>
</ul>
<div class="lb-trans"><ul>
<li>ALHC 股票飙升 400%——以下是牛市未结束的原因</li>
</ul>
</div><p>Alignment Healthcare NASDAQ: ALHC executives said the company remains confident in its second-quarter outlook, citing stable medical cost trends, continued visibility into utilization and opportunities to expand margins as it grows outside California.</p>
<div class="lb-trans"><p>Alignment Healthcare NASDAQ: ALHC 的高管表示，公司对第二季度的前景保持信心，指出医疗成本趋势稳定，利用率持续可见，并有机会在加州以外扩大利润空间。</p>
</div><p>Get <strong>Alignment Healthcare</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>Alignment Healthcare</strong> 的提醒：</p>
</div><p>Speaking at an analyst-led question-and-answer session, Chairman and CEO John Kao and CFO Jim Head discussed the Medicare Advantage company’s guidance, growth strategy, provider relationships, risk adjustment environment and technology investments.</p>
<div class="lb-trans"><p>在一次由分析师主导的问答环节中，董事长兼首席执行官 John Kao 和首席财务官 Jim Head 讨论了医疗保险优势公司的指导方针、增长战略、提供者关系、风险调整环境和技术投资。</p>
</div><h2>Executives Say Medical Cost Trends Remain Stable</h2>
<div class="lb-trans"><h2>高管表示医疗成本趋势保持稳定</h2>
</div><p>Head said Alignment’s second-quarter guide reflects a “pretty strong improvement” for the first half of the year, including 60 basis points of medical benefit ratio improvement, 40 basis points of SG&amp;A improvement and nearly 100 basis points of adjusted EBITDA improvement. He also pointed to 80% year-over-year growth.</p>
<div class="lb-trans"><p>Head 表示，Alignment 的第二季度指导反映了上半年 “相当强劲的改善”，包括医疗福利比率改善 60 个基点，销售、一般和行政费用改善 40 个基点，以及调整后 EBITDA 改善近 100 个基点。他还指出，年同比增长达 80%。</p>
</div><p>Asked about the expected step down in MBR from the first quarter to the second quarter, Head said that pattern is typical and driven by two factors: different utilization seasonality in the second quarter versus the first quarter and the influence of Medicare Part D. He said this year’s step down is larger than in the past, at about 140 basis points, but added that when adjusting for factors such as a January utilization management headwind, Part D effects and heavier second-quarter medical costs last year, the pattern appears consistent.</p>
<div class="lb-trans"><p>当被问及第一季度到第二季度的医疗福利比率预期下降时，Head 表示这种模式是典型的，由两个因素驱动：第二季度与第一季度的不同利用季节性以及医疗保险 D 部分的影响。他表示，今年的下降幅度大于以往，约为 140 个基点，但补充说，考虑到一月的利用管理逆风、D 部分的影响以及去年第二季度的医疗成本较高，这一模式似乎是一致的。</p>
</div><p>“We feel pretty good about our second quarter guide and how that’s playing out,” Head said.</p>
<div class="lb-trans"><p>“我们对第二季度的指导及其表现感到相当满意，” Head 说。</p>
</div><p>On medical trend, Head described conditions as “stable.” He said inpatient admissions, inpatient acute and non-acute costs, supplemental benefits and Part D are all performing in line with expectations. While the company has a somewhat different membership mix this year, including more new members who may be more acute, Head said trends have remained consistent with the company’s forecast.</p>
<div class="lb-trans"><p>在医疗趋势方面，Head 描述情况为 “稳定”。他说，住院入院、急性和非急性住院成本、补充福利和 D 部分的表现均符合预期。尽管公司今年的会员组成有所不同，包括更多可能更急需的新增会员，但 Head 表示趋势与公司的预测保持一致。</p>
</div><h2>Data Visibility Remains Central to Alignment’s Model</h2>
<div class="lb-trans"><h2>数据可见性仍然是 Alignment 模型的核心</h2>
</div><p>Kao said Alignment’s visibility into medical trend is rooted in a “bottoms-up build” that starts at the member level and aggregates up to groups and markets. He said the company tracks metrics including member satisfaction, admissions per thousand, readmission rates, emergency room rates, prevention-related indicators and quality.</p>
<div class="lb-trans"><p>Kao 表示，Alignment 对医疗趋势的可见性源于一种 “自下而上构建” 的方式，从会员层面开始，汇总到团体和市场。他表示，公司跟踪的指标包括会员满意度、每千人入院率、再入院率、急诊室率、预防相关指标和质量。</p>
</div><p>“High quality, low cost” has been a guiding principle from the company’s early days, Kao said. He added that Alignment’s systems allow management to review data daily and identify negative variances on a per-member, per-month basis.</p>
<div class="lb-trans"><p>“高质量、低成本” 是公司早期的指导原则，Kao 说。他补充说，Alignment 的系统使管理层能够每天审查数据，并识别每位会员每月的负面差异。</p>
</div><p>“This notion of transparency, visibility, and control lead to durability,” Kao said. He contrasted Alignment’s data capabilities with competitors whose back-end systems may require 30 to 45 days of reconciliation.</p>
<div class="lb-trans"><p>“这种透明度、可见性和控制力的概念导致了持久性，” Kao 说。他将 Alignment 的数据能力与竞争对手的后端系统进行了对比，后者可能需要 30 到 45 天的对账时间。</p>
</div><h2>Kao Sees Risk Adjustment Changes as Uncertain</h2>
<div class="lb-trans"><h2>Kao 认为风险调整变化不确定</h2>
</div><p>Kao said the final 2027 rate notice came in better than the preliminary version, in part because of a delay in risk adjustment data recalibration. He said Alignment believes it can do better than the 2.48% overall rate increase heading into the year, citing the company’s care-centric model.</p>
<div class="lb-trans"><p>Kao 表示，2027 年最终费率通知比初步版本更好，部分原因是风险调整数据重新校准的延迟。他表示，Alignment 相信它可以在进入新的一年时做得比 2.48% 的整体费率增长更好，引用了公司的以护理为中心的模型。</p>
</div><p>Still, Kao said the rate increase remains below overall trend and may continue to pressure competitors. He argued that Alignment’s lower-cost model gives it an advantage when rates are flat or declining.</p>
<div class="lb-trans"><p>尽管如此，Kao 表示，费率增长仍低于整体趋势，可能继续对竞争对手施加压力。他认为，Alignment 的低成本模型在费率持平或下降时给予了其优势。</p>
</div><p>After recent discussions in Washington, D.C., Kao said it is unclear whether there will be material changes to the Medicare Advantage risk model in the near term. He said officials appeared cautious about whether there is enough time to implement larger changes, including approaches tied to inferred diagnoses.</p>
<div class="lb-trans"><p>在最近与华盛顿特区的讨论后，Kao 表示，目前尚不清楚医疗保险优势风险模型是否会在短期内发生重大变化。他表示，官员们似乎对是否有足够的时间实施更大变化持谨慎态度，包括与推断诊断相关的方法。</p>
</div><p>Kao also said future attention may shift beyond health plans toward broader “program integrity” across the healthcare supply chain, including pharmacy, fraud, waste and abuse, and billing accuracy among health systems and integrated delivery networks.</p>
<div class="lb-trans"><p>Kao 还表示，未来的关注可能会从健康计划转向更广泛的 “项目完整性”，涵盖整个医疗供应链，包括药房、欺诈、浪费和滥用，以及健康系统和综合交付网络的账单准确性。</p>
</div><h2>Expansion Outside California Offers Margin Opportunity</h2>
<div class="lb-trans"><h2>加州以外的扩张提供了利润机会</h2>
</div><p>Kao said Alignment is pleased with its growth outside California, where about 20% of members are now located. He said the company was intentional in capturing C-SNP and D-SNP members this year, which he described as among its most profitable populations because of Alignment’s care model.</p>
<div class="lb-trans"><p>Kao 表示，Alignment 对其在加州以外的增长感到满意，目前约 20% 的会员位于该地区。他表示，公司在今年有意捕捉 C-SNP 和 D-SNP 会员，他将其描述为最有利可图的人群，因为 Alignment 的护理模型。</p>
</div><p>He acknowledged that medical loss ratios outside California are naturally higher given the volume of new growth, but said the company expects cohort maturation and embedded earnings to benefit future years.</p>
<div class="lb-trans"><p>他承认，加州以外的医疗损失比率自然较高，考虑到新增长的数量，但表示公司预计群体成熟和嵌入收益将有利于未来几年。</p>
</div><p>Kao said expansion will continue to be evaluated through filters such as whether the company can find like-minded providers that understand and support Alignment’s model. He said the company plans to enter markets in 2027 where it has identified those providers, including health systems interested in Alignment’s approach and potential market share gains.</p>
<div class="lb-trans"><p>Kao 表示，扩张将继续通过过滤器进行评估，例如公司是否能够找到理解并支持 Alignment 模型的志同道合的提供者。他表示，公司计划在 2027 年进入已识别这些提供者的市场，包括对 Alignment 方法感兴趣的健康系统和潜在市场份额的增长。</p>
</div><p>Outside California, Kao said Alignment often functions as the IPA itself, engaging directly with physician practices on Star ratings gap closures, risk adjustment and integration of its Care Anywhere clinical model. That differs from parts of California, where independent physician associations may sit between the company and providers.</p>
<div class="lb-trans"><p>在加州以外，Kao 表示，Alignment 通常作为 IPA 本身运作，直接与医生实践合作，解决星级评分差距、风险调整和整合其 Care Anywhere 临床模型。这与加州的部分地区不同，独立医生协会可能在公司与提供者之间。</p>
</div><p>“Because we’re the IPA, there’s more margin opportunity for us,” Kao said of markets outside California.</p>
<div class="lb-trans"><p>“因为我们是 IPA，所以在加州以外的市场中我们有更多的利润机会，” Kao 说。</p>
</div><h2>Technology, AI and Margin Targets</h2>
<div class="lb-trans"><h2>技术、人工智能和利润目标</h2>
</div><p>Kao said Alignment has been “intentionally quiet” about its AVA technology platform in recent quarters because it is rebuilding and enhancing the tech stack. He said new large language models could improve workflows by providing faster, more accurate and timelier data, with potential benefits for both medical loss ratio and general and administrative expenses.</p>
<div class="lb-trans"><p>Kao 表示，Alignment 在最近几个季度对其 AVA 技术平台 “故意保持低调”，因为它正在重建和增强技术架构。他表示，新的大型语言模型可以通过提供更快、更准确和及时的数据来改善工作流程，对医疗损失比率和一般及行政费用都有潜在好处。</p>
</div><p>“You’re going to start hearing us start using the word AI first soon,” Kao said, adding that the company expects to deploy AI use cases across the business.</p>
<div class="lb-trans"><p>“你们很快就会开始听到我们首先使用人工智能这个词，” Kao 说，并补充说，公司预计将在业务中部署人工智能用例。</p>
</div><p>The executives also discussed recent hires, including Mark Kent, who will focus on AVA Health Partners, and Shane Hochradel, who is joining as chief operating officer with experience in claims systems, provider data and provider engagement from Elevance Health. Kao also said current board chairman Joseph Konowiecki will take on a more active strategic role, while Kao agreed to serve as chairman to preserve governance structure.</p>
<div class="lb-trans"><p>高奥还讨论了最近的招聘情况，包括将专注于 AVA Health Partners 的马克·肯特，以及将作为首席运营官加入的香农·霍赫拉德尔，他在 Elevance Health 拥有索赔系统、提供者数据和提供者参与方面的经验。高奥还表示，现任董事会主席约瑟夫·科诺维基将承担更积极的战略角色，而高奥同意担任主席以维护治理结构。</p>
</div><p>On long-term profitability, Kao reiterated a 5% to 6% margin opportunity, while noting the Medicare Advantage 85% medical loss ratio requirement. He said Alignment can meet that requirement through richer supplemental benefits, stronger provider partnerships or other investments that support durability.</p>
<div class="lb-trans"><p>关于长期盈利能力，高奥重申了 5% 到 6% 的利润空间机会，同时指出医疗保险优势计划 85% 的医疗损失率要求。他表示，Alignment 可以通过更丰富的补充福利、更强的提供者合作关系或其他支持可持续性的投资来满足该要求。</p>
</div><p>Kao said the company will continue pursuing balanced growth and margin expansion market by market, supported by technology and scale-oriented leadership. He also reiterated Alignment’s ambition to reach at least 1 million members, though he declined to provide a timeline.</p>
<div class="lb-trans"><p>高奥表示，公司将继续在每个市场追求平衡增长和利润扩张，依靠技术和规模导向的领导力支持。他还重申了 Alignment 希望至少达到 100 万会员的雄心，尽管他拒绝提供时间表。</p>
</div><h2>About Alignment Healthcare NASDAQ: ALHC</h2>
<div class="lb-trans"><h2>关于 Alignment Healthcare NASDAQ: ALHC</h2>
</div><p>Alignment Healthcare, Inc NASDAQ: ALHC is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.</p>
<div class="lb-trans"><p>Alignment Healthcare, Inc NASDAQ: ALHC 是一家专注于为医疗保险优势受益人提供基于价值的医疗服务的公司。该公司利用一种综合护理模式，结合居家临床服务、远程医疗能力和数字健康工具，以管理慢性病、改善结果和提升患者体验。</p>
</div><p>At the core of Alignment Healthcare's approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.</p>
<div class="lb-trans"><p>Alignment Healthcare 方法的核心是一种专有技术平台，该平台聚合实时临床和索赔数据，以支持预防护理、风险分层和个性化护理计划。</p>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。如对本故事有任何问题或意见，请发送邮件至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Alignment Healthcare Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资$1,000 在 Alignment Healthcare 吗？</h2>
</div><p>Before you consider Alignment Healthcare, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 Alignment Healthcare 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Alignment Healthcare wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而 Alignment Healthcare 并不在名单上。</p>
</div><p>While Alignment Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Alignment Healthcare 目前在分析师中获得了适度买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>查看这五只股票</p>
</div>

Alignment Healthcare 维持第二季度的展望，因稳定的成本和新市场提升了利润率的预期